Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate…
- Resource Type
- Journal
- Language
- English
- Region
- Japan
- Price
- $68.00
- Article Title
- Comparison of Clinical Equivalence of Infliximab and its Biosimilar Combinations with Methotrexate in the Treatment of Rheumatoid Arthritis
- Publication
- Japanese Journal of Clinical Pharmacology and Therapeutics/ 臨床薬理
- ISSN
- 0388-1601
- Volume
- 53
- Issue
- 2
- Year
- 2022
- Pages
- 15-24
- Data Format
- Subject Fields
- Clinical Medicine
- Note
- Full text is usually delivered within 1-2 hours
